Stamford, CT -- (SBWIRE) -- 01/15/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: DETOUR GOLD CORP (OTCMKTS:DRGDF), OncoSec Medical Inc (OTCMKTS:ONCS), Affymax, Inc. (OTCMKTS:AFFY), Tranzbyte Corp (OTCMKTS:ERBB)
DETOUR GOLD CORP (OTCMKTS:DRGDF) opened the session at $5.29, trading in a range of $5.01 - $5.37. The stock showed a negative performance of -5.69% in the last trading session from its previous close of $5.3402 and closed at $5.04. The stock traded on a volume of 39,259 shares and the average volume of the stock remained 81,763 shares. Detour Gold Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada. The company primarily explores for gold. It primarily holds a 100% interest in the Detour Lake project covering an area of approximately 566 square kilometers in Northeastern Ontario.
Has DRGDF Found The Bottom and Ready To Move Up? Find Out Here
OncoSec Medical Inc (OTCMKTS:ONCS) traded 7.02 million shares in the last business day while the average volume of the stock remained 3.43 million shares. The stock showed a negative movement of -5.56% to end at $0.510. The 52 week range of the stock remained $0.18 - $0.57. OncoSec Medical Incorporated is a drug-medical device and therapeutic company. The Company is focused on designing, developing and commercializing medical approaches for the treatment of solid tumors that have unmet medical needs or where approved therapies are inadequate based on their efficacy or side-effects.
Has ONCS Found The Bottom And Ready To Gain Momentum? Find Out Here
Affymax, Inc. (OTCMKTS:AFFY) reported 340,189 shares were exchanged during the last trade, while the average volume is about 373,110 shares. The stock dropped -5.21% and finished the day at $0.910. The beta of the stock is recorded at 1.35. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.
Why Should Investors Buy AFFY After the Recent Fall? Just Go Here and Find Out
Tranzbyte Corp (OTCMKTS:ERBB) shares dropped -5.15 percent from its previous close of $0.0097 to close at $0.0092. Traded with volume of 164.55 million shares in the prior session and the average volume of the stock remained 115.27million shares. The Tranzbyte Corporation is a driving force behind Altitude Organic Corporation, One Bode, The YO! Debit Card, and ProximaRF. Altitude Organic Corporation is a medical marijuana dispensary brand. It has developed retailing, branding, and commercial cultivating strategies in conjunction with its licensed medical marijuana retail dispensaries operating under the Altitude Organic Medicine brand name.
Will ERBB Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)